PEGylated liposomes prepared with polyborane instead of cholesterol for BNCT: characteristics and biodistribution evaluation
- 258 Downloads
Recently, boron neutron capture therapy (BNCT) has been focused on, which is a cancer therapy using nuclear reaction between boron and thermal neutron. To selectively destroy cancer cells, the high accumulation and selective delivery of boron-10 (10B) into tumor tissue are required. We have developed polyborane from 1,7-dicarba-closo-dodecaborane as a boron carrier. To evaluate tumor accumulation of polyborane, PEGylated liposomes were chosen as carrier. The mean volume diameters of polyborane-embedded liposomes were 50, 100, and 200 nm, respectively. They were injected into the tail vein of tumor-bearing mice. Twenty-four hours later, mice were killed and biodistribution of boron was determined using the inductively coupled plasma atomic emission spectrometry. At 24 h after injection, 50 nm bare liposome and 100 nm PEGylated liposome were found in tumor with high boron levels. Moreover, 50 nm bare liposome showed high tumor/blood ratios of boron concentration, and their usability for BNCT was suggested.
KeywordsBoron neutron capture therapy PEGylation Liposomes Drug delivery Dicarba-closo-dodecaborane Biodistribution
This work was supported by Program for Development of Strategic Research Center in Private Universities supported by MEXT (2010–2014).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H (2004) Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Control Rel 98:195–207. doi: 10.1016/j.jconrel.2004.04.018 CrossRefGoogle Scholar
- 3.Vicente MGH, Wickramasinghe A, Nurco DJ, Wang HJH, Nawrocky MM, Makar M, Miura M (2003) Synthesis, toxicity and biodistribution of two 5,15-di[3,5-(nidocarboranylmethyl)phenyl]porphyrins in EMT-6 tumor bearing mice. Bioorganic Med Chem 11:3101–3108. doi: 10.1016/S0968-0896(03)00240-2 CrossRefGoogle Scholar
- 14.Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH (1997) Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine. J Neuro-Oncol 33:59–70. doi: 10.1023/A:1005769214899 CrossRefGoogle Scholar
- 20.Zheng Z, Jiang W, Zinn AA, Knobler CB, Hawthorne MF (1995) Facile electrophilic iodination of icosahedral carboranes. Synthesis of carborane derivatives with boron-carbon bonds via the palladium-catalyzed reaction of diiodocarboranes with Grignard reagents. Inorg Chem 34:2095–2100. doi: 10.1021/ic00112a023 CrossRefGoogle Scholar
- 22.Thirumamagal BTS, Zhao XB, Bandyopadhyaya AK, Narayanasamy S, Johnsamuel J, Tiwari R, Golightly DW, Patel V, Jehning BT, Backer MV, Barth RF, Lee RJ, Backer JM, Tjarks W (2006) Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Bioconjug Chem 17:1141–1150. doi: 10.1021/jm9900725 CrossRefGoogle Scholar